Bafna Pharmaceuticals Limited

80

INR
+0.95(+1.20%)
As of November 14, 2024 10:00:00 AM

Bafna Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 77.47
High: 80

All time High

222.45

Price Change 1h

+₹1.95 +2.50%

Price Change 1d

+₹1.95 +2.50%

Price Change 1w

+₹0.49 +0.62%

Bafna Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

191.62 Cr

About Bafna Pharmaceuticals Limited Share

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

363

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Bafna Pharmaceuticals Limited's (NSE:BAFNAPH) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

FAQs

Bafna Pharmaceuticals Limited

80

INR
+0.95(+1.20%)
As of November 14, 2024 10:00:00 AM

Bafna Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 77.47
High: 80

All time High

222.45

Price Change 1h

+₹1.95 +2.50%

Price Change 1d

+₹1.95 +2.50%

Price Change 1w

+₹0.49 +0.62%

Bafna Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

191.62 Cr

About Bafna Pharmaceuticals Limited Share

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

363

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Bafna Pharmaceuticals Limited's (NSE:BAFNAPH) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

FAQs